activated dimeticone: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
activated dimeticone: clinical details
Prescribing considerations
- Confirm that persistent crying or abdominal symptoms do not indicate feeding difficulty, reflux, constipation, allergy, infection or another illness.
- Explain that the product is licensed for wind-related griping, but research has not shown convincing benefit for infant colic.
- Review thyroid treatment and formulation excipients before use.
Contraindications and cautions
- Hypersensitivity to activated dimeticone or any excipient.
- Because the selected product contains sucrose: hereditary fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency.
Monitoring
- No routine laboratory monitoring is specified.
- Reassess persistent or worsening symptoms, feeding, hydration and growth, and consider an alternative diagnosis.
Clinical pharmacology
A chemically inert, non-systemically absorbed surface-active silicone that reduces gas-bubble surface tension within intestinal contents and is excreted unchanged.
Formulation and product differences
- The selected product is a translucent white oral suspension supplied with an oral syringe.
- It contains sucrose, dill oil, carbomer and methyl, ethyl and propyl parahydroxybenzoates; excipients may determine suitability.
- The oral syringe should be rinsed with warm water and dried, not steam-sterilised.
activated dimeticone interactions
Few interactions are expected because activated dimeticone is not absorbed, but one clinically relevant interaction is recognised.
Levothyroxine
Activated dimeticone may bind levothyroxine in the gut and reduce its absorption; seek pharmacist or prescriber advice if the infant receives thyroid treatment.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.